Concepedia

Jeffrey L. Larson

JL

26

Publications

1.8K

Citations

21

H-Index

1979

Active since

Affiliations

Research Triangle Park Foundation(Current)

Washington State University

Pfizer (United States)

Centers for Disease Control and Prevention

Eli Lilly (United States)

Jeffrey L. Larson is an author at Research Triangle Park Foundation specializing in medicine, toxicology, and pharmacology.

Top concepts

MedicineToxicologyPharmacologyHealthPhysiologyLiver PhysiologyPathologyOxidative StressMolecular BiologyEnvironmental Toxicology

Publications per year

1979–2022

26

Publications

26

Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate

Richard J. Bull, Idalia M. Sanchez, Mark A. Nelson et al. · Toxicology · 1990 · 289 citations

Tumor Biology, Hepatology, Oncogenic Agent +12

Antiretroviral Activity of the Anti‐CD4 Monoclonal Antibody TNX‐355 in Patients Infected with HIV Type 1

Daniel R. Kuritzkes, Jeffrey M. Jacobson, William G. Powderly et al. · The Journal of Infectious Diseases · 2004 · 193 citations

Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice

Jeffrey L. Larson, Richard J. Bull · Toxicology and Applied Pharmacology · 1992 · 156 citations

Energy Metabolism, Biochemistry, Medicine +10

Vital Forces: Regulative Principles or Constitutive Agents? A Strategy in German Physiology, 1786-1802

Jeffrey L. Larson · Isis · 1979 · 115 citations

Mechanobiology, Physiological Principle, Physiological Research +9

Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein

Gallen Triana‐Baltzer, Larisa V. Gubareva, John M. Nicholls et al. · PLoS ONE · 2009 · 107 citations · Full text

Rows per page

1–5 of 26